Cargando…
25-Hydroxyvitamin D potentializes extracellular cathelicidin release from human PBMC stimulated ex vivo with either bacterial (LPS) or viral (P: IC) mimetics
Human cathelicidin refers to the cationic antimicrobial peptide hCAP18/LL-37. LL-37 is formed by cleavage of the propeptide hCAP18 coded by the CAMP gene. The active form of vitamin D, 1,25-dihydroxyvitamin D (1,25(OH)D), has been shown to induce the CAMP gene expression through promoter activation....
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727486/ https://www.ncbi.nlm.nih.gov/pubmed/34985728 http://dx.doi.org/10.1007/s13105-021-00868-z |
_version_ | 1784626540961595392 |
---|---|
author | Aldekwer, Sahar Goncalves-Mendes, Nicolas Bingula, Rea Martinroche, Guillaume Lanchais, Kassandra Rougé, Stéphanie Farges, Marie-Chantal Rossary, Adrien Diab-Assaf, Mona Vasson, Marie-Paule Talvas, Jérémie |
author_facet | Aldekwer, Sahar Goncalves-Mendes, Nicolas Bingula, Rea Martinroche, Guillaume Lanchais, Kassandra Rougé, Stéphanie Farges, Marie-Chantal Rossary, Adrien Diab-Assaf, Mona Vasson, Marie-Paule Talvas, Jérémie |
author_sort | Aldekwer, Sahar |
collection | PubMed |
description | Human cathelicidin refers to the cationic antimicrobial peptide hCAP18/LL-37. LL-37 is formed by cleavage of the propeptide hCAP18 coded by the CAMP gene. The active form of vitamin D, 1,25-dihydroxyvitamin D (1,25(OH)D), has been shown to induce the CAMP gene expression through promoter activation. We previously failed to demonstrate in a clinical trial that supplementation of 25-hydroxyvitamin D (25(OH)D) improves LL-37 serum levels. The aim of this work was to evaluate the impact of 25(OH)D supplementation on intracellular expression of CAMP and secretion of LL-37 in an ex vivo model using the peripheral blood mononuclear cells (PBMC). PBMC collected from healthy donors and incubated with different concentrations of 25(OH)D (0 ng/ml: control (D0); 25 ng/ml: deficient (D25); 75 ng/ml: physiological (D75); 125 ng/ml: supraphysiological (D125)) were stimulated or not with lipopolysaccharide (LPS, 100 ng/ml) or synthetic double-stranded RNA Poly (I: C) (PIC, 10 µg/ml). The intracellular expressions of the CAMP gene and the hCAP18 peptide were measured respectively after 24-h and 48-h incubation periods. The concentration of LL-37 was determined in the culture medium after 48-h incubation. 25(OH)D significantly induced CAMP gene expression at 24 h with a maximum effect at a dose of D125 in either unstimulated (tenfold expression) or stimulated (LPS: 100-fold expression; PIC: 15-fold expression) conditions. Intracellular hCAP18 peptide was overexpressed at 48 h under unstimulated (1.5-fold, D125) and stimulated conditions, LPS (twofold, D125) and PIC (2.5-fold, D125). The secretion of LL-37 in the culture medium was significantly induced by 25(OH)D only in both stimulated (LPS and PIC) conditions in a dose-dependent manner. Our results demonstrate that 25(OH)D incubation increases intracellular expression of CAMP and hCAP18, but extracellular secretion of LL-37 antimicrobial peptide is increased by 25(OH)D only when PBMC from healthy donors were stimulated with bacterial or viral immune mimetic. |
format | Online Article Text |
id | pubmed-8727486 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-87274862022-01-05 25-Hydroxyvitamin D potentializes extracellular cathelicidin release from human PBMC stimulated ex vivo with either bacterial (LPS) or viral (P: IC) mimetics Aldekwer, Sahar Goncalves-Mendes, Nicolas Bingula, Rea Martinroche, Guillaume Lanchais, Kassandra Rougé, Stéphanie Farges, Marie-Chantal Rossary, Adrien Diab-Assaf, Mona Vasson, Marie-Paule Talvas, Jérémie J Physiol Biochem Original Article Human cathelicidin refers to the cationic antimicrobial peptide hCAP18/LL-37. LL-37 is formed by cleavage of the propeptide hCAP18 coded by the CAMP gene. The active form of vitamin D, 1,25-dihydroxyvitamin D (1,25(OH)D), has been shown to induce the CAMP gene expression through promoter activation. We previously failed to demonstrate in a clinical trial that supplementation of 25-hydroxyvitamin D (25(OH)D) improves LL-37 serum levels. The aim of this work was to evaluate the impact of 25(OH)D supplementation on intracellular expression of CAMP and secretion of LL-37 in an ex vivo model using the peripheral blood mononuclear cells (PBMC). PBMC collected from healthy donors and incubated with different concentrations of 25(OH)D (0 ng/ml: control (D0); 25 ng/ml: deficient (D25); 75 ng/ml: physiological (D75); 125 ng/ml: supraphysiological (D125)) were stimulated or not with lipopolysaccharide (LPS, 100 ng/ml) or synthetic double-stranded RNA Poly (I: C) (PIC, 10 µg/ml). The intracellular expressions of the CAMP gene and the hCAP18 peptide were measured respectively after 24-h and 48-h incubation periods. The concentration of LL-37 was determined in the culture medium after 48-h incubation. 25(OH)D significantly induced CAMP gene expression at 24 h with a maximum effect at a dose of D125 in either unstimulated (tenfold expression) or stimulated (LPS: 100-fold expression; PIC: 15-fold expression) conditions. Intracellular hCAP18 peptide was overexpressed at 48 h under unstimulated (1.5-fold, D125) and stimulated conditions, LPS (twofold, D125) and PIC (2.5-fold, D125). The secretion of LL-37 in the culture medium was significantly induced by 25(OH)D only in both stimulated (LPS and PIC) conditions in a dose-dependent manner. Our results demonstrate that 25(OH)D incubation increases intracellular expression of CAMP and hCAP18, but extracellular secretion of LL-37 antimicrobial peptide is increased by 25(OH)D only when PBMC from healthy donors were stimulated with bacterial or viral immune mimetic. Springer Netherlands 2022-01-05 2022 /pmc/articles/PMC8727486/ /pubmed/34985728 http://dx.doi.org/10.1007/s13105-021-00868-z Text en © The Author(s) under exclusive licence to University of Navarra 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article Aldekwer, Sahar Goncalves-Mendes, Nicolas Bingula, Rea Martinroche, Guillaume Lanchais, Kassandra Rougé, Stéphanie Farges, Marie-Chantal Rossary, Adrien Diab-Assaf, Mona Vasson, Marie-Paule Talvas, Jérémie 25-Hydroxyvitamin D potentializes extracellular cathelicidin release from human PBMC stimulated ex vivo with either bacterial (LPS) or viral (P: IC) mimetics |
title | 25-Hydroxyvitamin D potentializes extracellular cathelicidin release from human PBMC stimulated ex vivo with either bacterial (LPS) or viral (P: IC) mimetics |
title_full | 25-Hydroxyvitamin D potentializes extracellular cathelicidin release from human PBMC stimulated ex vivo with either bacterial (LPS) or viral (P: IC) mimetics |
title_fullStr | 25-Hydroxyvitamin D potentializes extracellular cathelicidin release from human PBMC stimulated ex vivo with either bacterial (LPS) or viral (P: IC) mimetics |
title_full_unstemmed | 25-Hydroxyvitamin D potentializes extracellular cathelicidin release from human PBMC stimulated ex vivo with either bacterial (LPS) or viral (P: IC) mimetics |
title_short | 25-Hydroxyvitamin D potentializes extracellular cathelicidin release from human PBMC stimulated ex vivo with either bacterial (LPS) or viral (P: IC) mimetics |
title_sort | 25-hydroxyvitamin d potentializes extracellular cathelicidin release from human pbmc stimulated ex vivo with either bacterial (lps) or viral (p: ic) mimetics |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727486/ https://www.ncbi.nlm.nih.gov/pubmed/34985728 http://dx.doi.org/10.1007/s13105-021-00868-z |
work_keys_str_mv | AT aldekwersahar 25hydroxyvitamindpotentializesextracellularcathelicidinreleasefromhumanpbmcstimulatedexvivowitheitherbacteriallpsorviralpicmimetics AT goncalvesmendesnicolas 25hydroxyvitamindpotentializesextracellularcathelicidinreleasefromhumanpbmcstimulatedexvivowitheitherbacteriallpsorviralpicmimetics AT bingularea 25hydroxyvitamindpotentializesextracellularcathelicidinreleasefromhumanpbmcstimulatedexvivowitheitherbacteriallpsorviralpicmimetics AT martinrocheguillaume 25hydroxyvitamindpotentializesextracellularcathelicidinreleasefromhumanpbmcstimulatedexvivowitheitherbacteriallpsorviralpicmimetics AT lanchaiskassandra 25hydroxyvitamindpotentializesextracellularcathelicidinreleasefromhumanpbmcstimulatedexvivowitheitherbacteriallpsorviralpicmimetics AT rougestephanie 25hydroxyvitamindpotentializesextracellularcathelicidinreleasefromhumanpbmcstimulatedexvivowitheitherbacteriallpsorviralpicmimetics AT fargesmariechantal 25hydroxyvitamindpotentializesextracellularcathelicidinreleasefromhumanpbmcstimulatedexvivowitheitherbacteriallpsorviralpicmimetics AT rossaryadrien 25hydroxyvitamindpotentializesextracellularcathelicidinreleasefromhumanpbmcstimulatedexvivowitheitherbacteriallpsorviralpicmimetics AT diabassafmona 25hydroxyvitamindpotentializesextracellularcathelicidinreleasefromhumanpbmcstimulatedexvivowitheitherbacteriallpsorviralpicmimetics AT vassonmariepaule 25hydroxyvitamindpotentializesextracellularcathelicidinreleasefromhumanpbmcstimulatedexvivowitheitherbacteriallpsorviralpicmimetics AT talvasjeremie 25hydroxyvitamindpotentializesextracellularcathelicidinreleasefromhumanpbmcstimulatedexvivowitheitherbacteriallpsorviralpicmimetics |